TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE LDL TEST MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE LDL TEST MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 DBMR MARKET POSITION GRID
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 KEY PRIMARY INSIGHTS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING AWARENESS AMONG PATIENT
3.1.2 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND OBESITY
3.1.3 INCREASING NUMBER OF GERIATRIC PEOPLE
3.1.4 GOVERNMENT INITIATIVES TO IMPROVE QUALITY OF TESTING
3.2 RESTRAINTS
3.2.1 RISKS ASSOCIATED WITH TESTS LIKE BLEEDING AND INFECTION
3.2.2 EMERGENCE OF NON-INVASIVE CHOLESTEROL TESTING METHODS
3.3 OPPORTUNITIES
3.3.1 HIGH GROWTH POSSIBILITY IN LDL TEST IN DEVELOPING COUNTRIES
3.3.2 PATIENT-INITIATED TESTING
3.4 CHALLENGES
3.4.1 PATIENT DATA SECURITY
3.4.2 EVOLVING REGULATORY POLICIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 EUROPE LDL TEST MARKET, BY COMPONENTS
6.1 OVERVIEW
6.2 KITS & REAGENTS
6.3 DEVICES
6.3.1 SPECTROPHOTOMETER
6.3.2 SYRINGES AND NEEDLES
6.3.3 OTHERS
6.4 SERVICES
7 EUROPE LDL TESTING MARKET, BY DISEASE
7.1 OVERVIEW
7.2 DIABETES
7.3 STROKE
7.4 ATHEROSCLEROSIS
7.5 OBESITY
7.6 DYSLIPIDEMIA
7.7 CAROTID ARTERY DISEASE
7.8 PERIPHERAL ARTERIAL DISEASE
7.9 ANGINA
7.10 OTHERS
8 EUROPE LDL TEST MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDERS
8.3 RETAIL
9 EUROPE LDL TEST MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.3 CLINICS
9.4 AMBULATORY CARE
9.5 RESEARCH LABORATORY
?
10 EUROPE LDL TEST MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 U.K
10.1.3 FRANCE
10.1.4 ITALY
10.1.5 SPAIN
10.1.6 SWITZERLAND
10.1.7 NETHERLANDS
10.1.8 RUSSIA
10.1.9 BELGIUM
10.1.10 TURKEY
10.1.11 REST OF EUROPE
11 EUROPE LDL TEST MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 SWOT ANALYSIS
12.1 STRENGTH
12.2 WEAKNESS
12.3 OPPORTUNITY
12.4 THREAT
12.5 DATA BRIDGE MARKET RESEARCH ANALYSIS
13 COMPANY PROFILE
13.1 F. HOFFMANN-LA ROCHE LTD
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 GEOGRAPHICAL PRESENCE
13.1.5 PRODUCT PORTFOLIO
13.1.6 RECENT DEVELOPMENTS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 GEOGRAPHICAL PRESENCE
13.2.5 PRODUCT PORTFOLIO
13.2.6 RECENT DEVELOPMENT
?
13.3 ABBOTT
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 GEOGRAPHICAL PRESENCE
13.3.5 PRODUCT PORTFOLIO
13.3.6 RECENT DEVELOPMENTS
13.4 SEKISUI DIAGNOSTICS
13.4.1 COMPANY SNAPSHOT
13.4.2 COMPANY SHARE ANALYSIS
13.4.3 GEOGRAPHICAL PRESENCE
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENT
13.5 ATLAS MEDICAL U.K
13.5.1 COMPANY SNAPSHOT
13.5.2 GEOGRAPHICAL PRESENCE
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 CELL BIOLABS, INC
13.6.1 COMPANY SNAPSHOT
13.6.2 GEOGRAPHICAL PRESENCE
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 DIASYS DIAGNOSTIC SYSTEMS GMBH
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENT
13.8 DIAZYME LABORATORIES, INC
13.8.1 COMPANY SNAPSHOT
13.8.2 GEOGRAPHICAL PRESENCE
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENTS
13.9 EUROFINS SCIENTIFIC
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 GEOGRAPHICAL PRESENCE
13.9.4 PRODUCT PORTFOLIO
13.9.5 RECENT DEVELOPMENT
?
13.10 EUROLYSER DIAGNOSTICA GMBH
13.10.1 COMPANY SNAPSHOT
13.10.2 GEOGRAPHICAL PRESENCE
13.10.3 PRODUCT PORTFOLIO
13.10.1 RECENT DEVELOPMENTS
13.11 EXPRESS BIOTECH INTERNATIONAL
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 HOME ACCESS HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 LABORATORY CORPORATION OF AMERICA
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 GEOGRAPHICAL PRESENCE
13.13.4 PRODUCT PORTFOLIO
13.13.5 RECENT DEVELOPMENTS
13.14 QUEST DIAGNOSTICS
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 GEOGRAPHICAL PRESENCE
13.14.4 PRODUCT PORTFOLIO
13.14.5 RECENT DEVELOPMENT
13.15 RANDOX LABORATORIES LTD
13.15.1 COMPANY SNAPSHOT
13.15.2 GEOGRAPHICAL PRESENCE
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 RECKONDIAGNOSTICS
13.16.1 COMPANY SNAPSHOT
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENTS
?
13.17 THERMO FISHER SCIENTIFIC INC
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 GEOGRAPHICAL PRESENCE
13.17.4 PRODUCT PORTFOLIO
13.17.5 RECENT DEVELOPMENTS
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS